Composition
Each 1 ml contains:
Rafoxanide – 30 mg
Pharmaceutical Form
Oral suspension
Pharmacological Properties
Rafoxanide is a salicylanilide anthelmintic with potent activity against liver flukes and certain nematodes. After oral administration, it is well absorbed and reaches peak serum levels within 24 hours. It has a prolonged half-life (approximately 4 days), ensuring sustained therapeutic effect. Rafoxanide is widely distributed in body tissues, particularly the liver, bile ducts, and intestines, which enhances its efficacy against tissue-dwelling parasites.
Target Species
Cattle, sheep, and goats
Indications for Use
Rafoxidad® 3% Suspension is indicated for the treatment and control of:
- Liver fluke infestations in their mature and immature stages (Fasciola hepatica, Fasciola gigantica, Dicrocoelium dendriticum)
- Blood-sucking gastrointestinal nematodes such as Haemonchus spp., Bunostomum spp., Trichuris spp., and Oesophagostomum spp.
- Larvae of tissue-invading flies, including Oestrus ovis, Lucilia spp., and Hypoderma spp.
Its broad-spectrum efficacy and long duration of action make it an ideal choice for fluke and parasite control, especially in high-risk grazing systems.
Contraindications
Do not use in animals producing milk for human consumption.
Undesirable Effects
None reported under normal usage conditions.
Posology and Method of Administration
Shake well before use.
- Cattle, sheep, and goats: 2.5 ml per 10 kg body weight (equivalent to 7.5 mg rafoxanide/kg)
- For optimal control, a repeat dose may be given after 4–6 weeks to target maturing flukes.
Overdose
No specific signs reported at recommended dosages.
Withdrawal Period
Do not slaughter animals for human consumption within 28 days of the last treatment.
Special Safety Precautions for the Person Administering the Product
No special precautions required. Wash hands after handling.
Special Precautions for Storage
Store in a dry place below 30°C.
Do not refrigerate.
For veterinary use only. Consult a veterinarian before use.
